kff employer health benefits survey 2025 glp-1 coverage Perspectives from employers on the costs and issues associated with covering agonists for weight loss A new car vs. health

Here are some factors to consider: Biological variation in GLP-1 receptors : Some people naturally have fewer or less sensitive GLP-1 receptors, meaning the medications appetite-lowering and gastric-slowing effects may not work as strongly similar to how people react more or less to blood pressure or cholesterol medications

They also have many potential side effects like swelling, headaches and increased cancer risk

Valencia Higuera Author Diverticular Disease

Crucially, the FDA has been explicit about the compounding of this drug: Retatrutide and cagrilintide cannot be used in compounding under federal law

Oral Administration in Children A 1995 study by Bellone and colleagues published in the European Journal of Endocrinology demonstrated that oral GHRP-6 retained GH-releasing activity in children with short stature